Cholestatic liver disease

J. A. Talwalkar, K. D. Lindor

Research output: Contribution to journalArticle

Abstract

Cholestatic liver disease remains a rare but increasingly recognized cause of illness affecting adults worldwide. Primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) are the two major cholestatic liver diseases. While there is much current evidence supporting an underlying immunologic process for both PBC and PSC, no unifying hypothesis exists to allow for the development of target-specific therapies. Because of advances in technology and the refinement of diagnostic modalities, an increasing number of individuals are being identified at earlier stages of disease who may benefit from existing treatment options. Despite improvements in the management of complications from end-stage liver disease and excellent long-term results from liver transplantation, a continued understanding of the clinico-pathologic processes responsible for cholestatic liver disease remains important.

Original languageEnglish (US)
Pages (from-to)28-35
Number of pages8
JournalPractical Gastroenterology
Volume25
Issue number1
StatePublished - 2001

Fingerprint

Liver Diseases
Sclerosing Cholangitis
Biliary Liver Cirrhosis
End Stage Liver Disease
Pathologic Processes
Liver Transplantation
Technology
Therapeutics

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Talwalkar, J. A., & Lindor, K. D. (2001). Cholestatic liver disease. Practical Gastroenterology, 25(1), 28-35.

Cholestatic liver disease. / Talwalkar, J. A.; Lindor, K. D.

In: Practical Gastroenterology, Vol. 25, No. 1, 2001, p. 28-35.

Research output: Contribution to journalArticle

Talwalkar, JA & Lindor, KD 2001, 'Cholestatic liver disease', Practical Gastroenterology, vol. 25, no. 1, pp. 28-35.
Talwalkar JA, Lindor KD. Cholestatic liver disease. Practical Gastroenterology. 2001;25(1):28-35.
Talwalkar, J. A. ; Lindor, K. D. / Cholestatic liver disease. In: Practical Gastroenterology. 2001 ; Vol. 25, No. 1. pp. 28-35.
@article{50e8c2b3f42c47baa41d0a910fa59dae,
title = "Cholestatic liver disease",
abstract = "Cholestatic liver disease remains a rare but increasingly recognized cause of illness affecting adults worldwide. Primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) are the two major cholestatic liver diseases. While there is much current evidence supporting an underlying immunologic process for both PBC and PSC, no unifying hypothesis exists to allow for the development of target-specific therapies. Because of advances in technology and the refinement of diagnostic modalities, an increasing number of individuals are being identified at earlier stages of disease who may benefit from existing treatment options. Despite improvements in the management of complications from end-stage liver disease and excellent long-term results from liver transplantation, a continued understanding of the clinico-pathologic processes responsible for cholestatic liver disease remains important.",
author = "Talwalkar, {J. A.} and Lindor, {K. D.}",
year = "2001",
language = "English (US)",
volume = "25",
pages = "28--35",
journal = "Practical Gastroenterology",
issn = "0277-4208",
publisher = "Shugar Publishing Inc.",
number = "1",

}

TY - JOUR

T1 - Cholestatic liver disease

AU - Talwalkar, J. A.

AU - Lindor, K. D.

PY - 2001

Y1 - 2001

N2 - Cholestatic liver disease remains a rare but increasingly recognized cause of illness affecting adults worldwide. Primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) are the two major cholestatic liver diseases. While there is much current evidence supporting an underlying immunologic process for both PBC and PSC, no unifying hypothesis exists to allow for the development of target-specific therapies. Because of advances in technology and the refinement of diagnostic modalities, an increasing number of individuals are being identified at earlier stages of disease who may benefit from existing treatment options. Despite improvements in the management of complications from end-stage liver disease and excellent long-term results from liver transplantation, a continued understanding of the clinico-pathologic processes responsible for cholestatic liver disease remains important.

AB - Cholestatic liver disease remains a rare but increasingly recognized cause of illness affecting adults worldwide. Primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) are the two major cholestatic liver diseases. While there is much current evidence supporting an underlying immunologic process for both PBC and PSC, no unifying hypothesis exists to allow for the development of target-specific therapies. Because of advances in technology and the refinement of diagnostic modalities, an increasing number of individuals are being identified at earlier stages of disease who may benefit from existing treatment options. Despite improvements in the management of complications from end-stage liver disease and excellent long-term results from liver transplantation, a continued understanding of the clinico-pathologic processes responsible for cholestatic liver disease remains important.

UR - http://www.scopus.com/inward/record.url?scp=0035146053&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035146053&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0035146053

VL - 25

SP - 28

EP - 35

JO - Practical Gastroenterology

JF - Practical Gastroenterology

SN - 0277-4208

IS - 1

ER -